Search For Lab Tests Here

 The Diabetes Prevention Program (DPP) Screening Panel is a critical tool in the early identification and management of prediabetes and diabetes. This panel utilizes targeted tests to evaluate an individual's blood sugar levels and their body's ability to process glucose over time. By accurately assessing these factors, the panel helps healthcare providers detect early signs of glycemic control issues, enabling timely intervention that can prevent the onset of diabetes or manage it effectively in its initial stages.

The Insulin and Glucose panel is a focused diagnostic tool used to evaluate blood sugar levels and insulin, the hormone responsible for regulating glucose uptake from the bloodstream into the cells. This panel includes two essential tests: one for measuring glucose levels and another for assessing insulin levels in the blood. Together, these tests provide valuable insights into the body's glucose metabolism and insulin function, which are crucial for diagnosing and managing diabetes and other metabolic disorders.

 The Thyroid Health Test Package (TSH and FT4) is a fundamental screening tool for assessing thyroid function. It includes two essential tests: T4 Free (FT4) and Thyroid Stimulating Hormone (TSH), which together provide a basic evaluation of thyroid health.

The Thyroid Panel Test measures Free T4 Index (T7), T3 Uptake, and Total T4 to evaluate thyroid hormone production and overall thyroid function. Abnormal results may indicate hypothyroidism, hyperthyroidism, or other endocrine disorders. Doctors use this test to investigate symptoms such as fatigue, weight changes, or irregular heartbeat and to monitor thyroid therapy. Results provide key insight into metabolism, energy balance, and endocrine health.

The Thyroid Stimulating Immunoglobulin (TSI) Test detects antibodies that stimulate the thyroid gland, often causing hyperthyroidism and Graves’ disease. High TSI levels may lead to symptoms such as weight loss, rapid heartbeat, or eye problems. Doctors order this test to confirm Graves’ disease, monitor treatment, or assess relapse risk. Results provide essential insight into autoimmune thyroid disorders and guide personalized management strategies.

The Cardio IQ™ ASCVD Risk Panel with Score combines essential lipid testing, Total Cholesterol, HDL Cholesterol, Triglycerides, Non-HDL and calculated components, and Direct LDL, with ASCVD risk scores. Risk estimates incorporate key patient inputs including current smoking status, systolic blood pressure, diabetes status, and whether high blood pressure is being treated.